{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:36Z","timestamp":1761540756549,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jaut.2007.02.009","type":"journal-article","created":{"date-parts":[[2007,3,24]],"date-time":"2007-03-24T07:06:08Z","timestamp":1174719968000},"page":"129-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Antiphospholipid antibodies: Lessons from the bench"],"prefix":"10.1016","volume":"28","author":[{"given":"Takao","family":"Koike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Bohgaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Amengual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2007.02.009_bib1","series-title":"Hughes Syndrome: antiphospholipid syndrome","first-page":"3","article-title":"Hughes syndrome: history","author":"Khamashta","year":"2006"},{"key":"10.1016\/j.jaut.2007.02.009_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.1989.tb04298.x","article-title":"Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation","volume":"71","author":"Schorer","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2007.02.009_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U","article-title":"Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes","volume":"41","author":"Reverter","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0038-1650552","article-title":"Coagulation activation and fibrinolytic imbalance in subjects with idopathic antiphospholipid antibodies \u2013 a crucial role for acquired free protein S deficiency","volume":"76","author":"Ames","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib5","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib6","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4049\/jimmunol.153.3.1328","article-title":"Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies","volume":"153","author":"Kornberg","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome","volume":"79","author":"Amengual","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.137.5.1532","article-title":"Antibody and immune complexes induce tissue factor production by human endothelial cells","volume":"137","author":"Tannenbaum","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0002-9378(12)90915-1","article-title":"Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis","volume":"168","author":"Branch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2007.02.009_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus","volume":"ii","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2007.02.009_bib11","first-page":"193","article-title":"Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus","volume":"56","author":"Koike","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"Beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jaut.2007.02.009_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1160\/TH03-10-0608","volume":"91","author":"Nojima","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1309\/YVQ6PX76XMYM3J29","article-title":"Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome","volume":"121","author":"Lopez","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaut.2007.02.009_bib15","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2007.02.009_bib17","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that induces a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaut.2007.02.009_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2007.02.009_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0140-6736(91)92482-H","article-title":"What is the \u201ctrue\u201d antigen for anticardiolipin antibodies?","volume":"337","author":"Koike","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2007.02.009_bib20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/art.1780390903","article-title":"Immunology of the antiphospholipid antibody syndrome","volume":"39","author":"Roubey","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib21","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4049\/jimmunol.161.4.2038","article-title":"Anti-\u03b22-glycoprotein I autoantibodies from patients with the \u201cantiphospholipid\u201d syndrome bind to \u03b22-glycoprotein I with low affinity: dimerization of \u03b22-glycoprotein I induces a significant increase in anti-\u03b22-glycoprotein I antibody affinity","volume":"161","author":"Sheng","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize \u03b22-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2007.02.009_bib23","first-page":"391","article-title":"Heterogeneous behavior of anti-\u03b22-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with \u03b22-glycoprotein I","volume":"27","author":"Tsutsumi","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2007.02.009_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2249.1999.00810.x","article-title":"Conformationally altered \u03b22-glycoprotein I is the antigen for anti-cardiolipin autoantibodies","volume":"115","author":"Chamley","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/ABAB:76:1:1","article-title":"Modification of \u03b22glycoprotein I by glutardialdehyde. Conformational changes and aggregation accompany exposure of the cryptic autoepitope","volume":"76","author":"Galazka","year":"1999","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jaut.2007.02.009_bib26","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V87.8.3262.bloodjournal8783262","article-title":"Human \u03b22-glycoprotein I as an anticardiolipin cofactor determined using deleted mutants expressed by a Baculovirus system","volume":"87","author":"Igarashi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4049\/jimmunol.155.3.1629","article-title":"Epitope specificity of monoclonal anti \u03b22-glycoprotien I antibodies derived from patients with the antiphospholipid syndrome","volume":"155","author":"Wang","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib28","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.160.8.3917","article-title":"Target recognition of \u03b22-glycoprotein I (\u03b22GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of \u03b22GPI in antibody binding","volume":"150","author":"George","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib29","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","article-title":"Anti-\u03b22 glycoprotein I (\u03b22GPI) autoantibodies recognize an epitope on the first domain of \u03b22GPI","volume":"95","author":"Iverson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaut.2007.02.009_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jaut.2000.0408","article-title":"\u03b22-glycoprotein I-anti-\u03b22-glycoprotein I interaction","volume":"15","author":"Koike","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2007.02.009_bib31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40\u2013Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib32","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","article-title":"Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change","volume":"107","author":"de Laat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/intimm\/dxh330","article-title":"Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies","volume":"17","author":"Kasahara","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","article-title":"Biochemistry and physiology of blood coagulation","volume":"82","author":"Mann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1096\/fasebj.9.10.7615158","article-title":"Regulation of the tissue factor gene","volume":"9","author":"Mackman","year":"1995","journal-title":"Faseb J"},{"key":"10.1016\/j.jaut.2007.02.009_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome","volume":"79","author":"Amengual","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0038-1655940","article-title":"Up-regulated tissue factor expression in antiphospholipid syndrome","volume":"77","author":"Atsumi","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0038-1656365","article-title":"Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity: studies in a thrombosis model","volume":"68","author":"Oosting","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0002-9378(12)90915-1","article-title":"Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis","volume":"168","author":"Branch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2007.02.009_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.2830410205","article-title":"Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant","volume":"41","author":"Schved","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaut.2007.02.009_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/096120339600500307","article-title":"Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus","volume":"5","author":"Martini","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2007.02.009_bib43","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2004-01-0145","article-title":"Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep","volume":"104","author":"Zhou","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U","article-title":"Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes","volume":"41","author":"Reverter","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib45","first-page":"179","article-title":"Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules","volume":"13","author":"Del Papa","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2007.02.009_bib46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib47","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.4049\/jimmunol.160.11.5572","article-title":"Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies","volume":"160","author":"Del Papa","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0090-1229(92)90232-D","article-title":"Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells","volume":"63","author":"Del Papa","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaut.2007.02.009_bib49","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","article-title":"Activation of cultured vascular endothelial cells by antiphospholipid antibodies","volume":"96","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaut.2007.02.009_bib50","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2007.02.009_bib51","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.20434","article-title":"Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin","volume":"50","author":"Vega-Ostertag","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib52","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/intimm\/dxh166","article-title":"The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies","volume":"16","author":"Bohgaki","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.thromres.2004.06.031","article-title":"Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies","volume":"114","author":"Pierangeli","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaut.2007.02.009_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/s-0037-1613313","article-title":"NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies","volume":"88","author":"Dunoyer-Geindre","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaut.2007.02.009_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni748","article-title":"p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment","volume":"3","author":"Saccani","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2007.02.009_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00024382-200207000-00010","article-title":"Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases","volume":"18","author":"McGilvray","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.jaut.2007.02.009_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2003.12.018","article-title":"Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal\u00a0kinase and p38","volume":"112","author":"Ohsawa","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaut.2007.02.009_bib58","doi-asserted-by":"crossref","first-page":"33428","DOI":"10.1074\/jbc.M105474200","article-title":"An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression","volume":"276","author":"Blum","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaut.2007.02.009_bib59","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","article-title":"Statin prevents tissue factor expression in human endothelial cells: role of Rho\/Rho-kinase and Akt pathways","volume":"105","author":"Eto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2007.02.009_bib60","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.0000014611.28864.1E","article-title":"NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells","volume":"105","author":"Herkert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2007.02.009_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","volume":"54","author":"Lopez-Pedrera","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2007.02.009_bib62","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","article-title":"High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II","volume":"275","author":"Ma","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaut.2007.02.009_bib63","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2007.02.009_bib64","doi-asserted-by":"crossref","first-page":"33831","DOI":"10.1074\/jbc.M212655200","article-title":"Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2\u2032","volume":"278","author":"Lutters","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841107000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841107000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:58:08Z","timestamp":1760255888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841107000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":64,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0896841107000297"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2007.02.009","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies: Lessons from the bench","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2007.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}